Wada, N. (2024) “Elevated Serum Growth Differentiation Factor 15 Levels as a Potential Biomarker of the Efficacy of Imeglimin in Individuals With Type 2 Diabetes Mellitus: An Exploratory Study”, Journal of Clinical Medicine Research, 16(10), pp. 503–508. doi:10.14740/jocmr6031.